Ex parte FRIEDMAN et al. - Page 3




                 Appeal No. 95-4914                                                                                                                     
                 Application No. 08/036,116                                                                                                             


                          2) claims 17-21 under 35 U.S.C. § 103 as unpatentable                                                                         
                 over de Vringer in view of Snyder.                                                                                                     
                          3) all appealed claims under the first paragraph of 35                                                                        
                 U.S.C. § 112, "written description requirement";                                                                                       
                          4) claims 3 and 30 under the first paragraph of 35 U.S.C.                                                                     
                 § 112, "enablement requirement"; and                                                                                                   
                                                                                                                                                       
                                  5) claims 3 and 22   under the second paragraph of 352                                                                                    
                 U.S.C. § 112 as indefinite.                                                                                                            
                                                                      THE SUBJECT MATTER ON APPEAL                                                     
                          The subject matter on appeal is directed to a composition                                                                     
                 for topical application of either pharmaceuticals or cosmetics                                                                         
                 which comprises submicron size droplets having a mean droplet                                                                          
                 size in the range of 0.05 to 0.5 microns (50 to 500                                                                                    
                 nanometers).  The droplets are comprised of three basic                                                                                
                 components ; about 0.5 to 30% of an oily liquid, about 0.1 to3                                                                                                                    

                          2Rather than claim 22, the examiner inadvertently refers                                                                      
                 to claim 33 in his answer.                                                                                                             
                          3The relative proportion ranges for the three components                                                                      
                 are apparently expressed as weight percents of each component                                                                          
                 based on the total weight of an emulsion containing the                                                                                
                 droplets.  See the specification at page 13, lines 14-16.                                                                              
                 However, compare the specification at page 3, lines 15-20.                                                                             
                                                                           3                                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007